Methods of treating lung cancer and other cancers by recombinant sars-cov-2 spike s1
AssigneeRush University Medical Center
InventorKalipada PAHAN
Life of this patent
Estimating the term…
Abstract
Described herein is a novel method of treating cancer in a patient in need thereof, comprising administering a therapeutically effective amount of SARS-CoV-2 Spike 51 polypeptide.
Claims14
A method of treating cancer comprising administering to a patient in need thereof, a therapeutically effective amount of a recombinant SARS-CoV-2 Spike S1 or a biologically active fragment thereof.
The method of claim 2 wherein the recombinant SARS-CoV-2 Spike S1 or a biologically active fragment thereof comprises the amino acid sequence of SEQ ID NO. 1.
An isolated SARS-CoV-2 Spike S1 polypeptide comprising the amino acid sequence of SEQ ID NO:
- 1.
A pharmaceutical composition comprising the polypeptide of claim 14 and a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.